Journal of Ovarian Research 2020

3 papers
The 2020 edition of the Journal of Ovarian Research focused on the regulatory roles of non-coding RNAs in cancer progression and prognosis. A significant portion of the research examined long non-coding RNA (lncRNA) signatures, such as the role of lncRNA THOR in promoting cellular progression via the IL-6/STAT3 pathway. Other studies utilized bioinformatics to evaluate the prognostic value of microRNAs like miR-30a and developed multi-lncRNA signatures to predict chemotherapy efficiency in patients with BRCA mutations. Methodological trends for the year included the use of comparative transcriptomics and hub gene identification to map molecular signaling hierarchies. Research also addressed cancer cell plasticity, stemness, and non-coding RNA sponging networks. These studies aimed to improve the early detection of asymptomatic malignancies and understand the molecular mechanisms driving tumor dynamics. Notable contributors to these themes included authors such as Jing Ge, Lili Shan, and Na Jing, whose work bridged molecular signaling with clinical outcomes and functional assays.

Top Research Directions

The 15 research directions with Journal of Ovarian Research 2020 papers, ranked by paper count, next to 2019. Share is the fraction of the edition’s papers in the direction.

#Direction20202019Share 2020Share 20192019 rank
1Biomarkers for Detecting Asymptomatic Late Stage Malignancies2066.7%0.0%—
2Computational Methods for microRNA Target Prediction1033.3%0.0%—
3Early Detection Strategies for Asymptomatic Disease Progression1133.3%100.0%3
4Interpreting Gene Expression via Functional Enrichment Analysis1033.3%0.0%—
5Long Noncoding RNAs as Prognostic Biomarkers1033.3%0.0%—
6Molecular Mechanisms of the Epithelial Mesenchymal Transition1033.3%0.0%—
7Multimodal Integration for Clinical Risk Stratification1033.3%0.0%—
8Network Centrality for Identifying Regulatory Hub Genes1033.3%0.0%—
9Prognostic Value Assessment via Cancer Survival Analysis1033.3%0.0%—
10Resolving the Functional Ambiguity of MicroRNAs1033.3%0.0%—
11Targeting the Mechanisms of Cancer Stem Cell Resistance1033.3%0.0%—
12Transcriptomic Signatures for Cancer Risk Stratification1033.3%0.0%—
13Uncovering the Biochemical Mechanisms of Long Noncoding RNAs1033.3%0.0%—
14Validating Causal Mechanisms via Pharmacological Pathway Inhibition1033.3%0.0%—
15Weighted Linear Models for Molecular Risk Stratification1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Ovarian Research 2020 papers: a paper credits every institution named in its affiliations, once. 6 institutions share 3 credited papers.

#InstitutionPapersShare20192019 rank
1004eeze55 133.3%0—
200qavst65 133.3%0—
3012f2cn18 133.3%0—
4Guangzhou Medical University 133.3%0—
5Huazhong University of Science and Technology 133.3%0—
6Tongji University 133.3%0—

Download all institutions as CSV

About this data

Papers. Journal of Ovarian Research 2020 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2019 use shares, since the edition went from 1 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-21 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Ovarian Research 2020”, https://lacuna.tiptreesystems.com/venue/journal-of-ovarian-research/2020.

Impactful Papers

Papers from Journal of Ovarian Research 2020 that shaped research clusters.

Influential

Papers

Title
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy
Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway